SEC Comment Letter for Streamex Corp. (STEX) (CIK 0001530766) (STEX) — Jun 30, 2017
Streamex Corp. (STEX) (CIK 0001530766)
Date: June 30, 2017 · CIK: 0001530766 · Accession: 0000000000-17-022969
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-218583
Letter
Mail Stop 3030 June 29 , 2017 Via E -mail Kenneth Londoner Chief Executive Officer BioSig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis, Minnesota 55426
Re: BioSig Technologies, Inc. Registration Statement on Form S-1 Filed June 8, 2017 File No. 333-218583
Dear Mr. Londoner:
We have limited our review of your registration statement to those issues we have addressed in our comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our com ments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you provide in response to these comments, w e may have additional comments.
Selling Shareholders, page 5
1. We note your reference here to warrants issued to “employees” of Laidlaw & Co. Please reconcile that disclosure with your Item 15 disclosure starting on page II -1 of your registration statem ent, which states that the warrants were issued to Laidlaw & Co. Also, revise your Item 15 disclosure to state the exemption upon which you relied to issue the warrants to employees of Laidlaw & Co.
Common Stock Placement Agent Warrants, page 16
2. Disclose the exercise price of the three -year warrants issued to Laidlaw & Company between October 2016 and March 2017.
Kenneth Londoner BioSig Technologies, Inc. June 29 , 2017 Page 2
We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any revi ew, comments, action or absence of action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration . Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.
Please contact Heather Percival at (202) 551 -3498 or me at (202) 551 -3528 with any questions.
Sincerely,
/s/ Amanda Ravitz
Show Raw Text
Mail Stop 3030 June 29 , 2017 Via E -mail Kenneth Londoner Chief Executive Officer BioSig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis, Minnesota 55426 Re: BioSig Technologies, Inc. Registration Statement on Form S-1 Filed June 8, 2017 File No. 333-218583 Dear Mr. Londoner: We have limited our review of your registration statement to those issues we have addressed in our comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our com ments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, w e may have additional comments. Selling Shareholders, page 5 1. We note your reference here to warrants issued to “employees” of Laidlaw & Co. Please reconcile that disclosure with your Item 15 disclosure starting on page II -1 of your registration statem ent, which states that the warrants were issued to Laidlaw & Co. Also, revise your Item 15 disclosure to state the exemption upon which you relied to issue the warrants to employees of Laidlaw & Co. Common Stock Placement Agent Warrants, page 16 2. Disclose the exercise price of the three -year warrants issued to Laidlaw & Company between October 2016 and March 2017. Kenneth Londoner BioSig Technologies, Inc. June 29 , 2017 Page 2 We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any revi ew, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration . Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Heather Percival at (202) 551 -3498 or me at (202) 551 -3528 with any questions. Sincerely, /s/ Amanda Ravitz Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Rick A. Werner, Esq. Haynes and Boone, LLP